RecruitingNCT05659901
Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease
Studying Pelizaeus-Merzbacher disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Enrollment
- 32 enrolled
- Eligibility
- 17 years · MALE
- Timeline
- 2022 – 2029
Study locations (8)
- Ionis Investigative Site, Atlanta, Georgia, United States
- Ionis Investigative Site, Philadelphia, Pennsylvania, United States
- Ionis Investigative Site, Clermont-Ferrand, France
- Ionis Investigative Site, Le Kremlin-Bicêtre, France
- Ionis Investigative Site, Göttingen, Germany
- Ionis Investigative Site, Tel Aviv, Israel
- Ionis Investigative Site, Milan, Italy
- Ionis Investigative Site, Amsterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05659901 on ClinicalTrials.govOther trials for Pelizaeus-Merzbacher disease
Additional recruiting or active studies for the same condition.